International journal of biological macromolecules
Cure8 research brief
Why This Matters
Researchers reported that two plant-derived fructans reduced chemically induced intestinal injury in a fruit fly model and modulated stress and regenerative signaling. For people interested in new IBD therapeutic leads, this identifies a preclinical candidate pathway but is far from clinical proof.
Who Should Pay Attention
Researchers; clinicians interested in basic-science developments; drug-discovery scientists focused on natural products and intestinal injury models.
Study Snapshot
Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract
What To Know
This preclinical journal abstract reports that two levan-type fructans (AMP80-1 and AMP80-2) purified from Allium macrostemon reduced dextran sulfate sodium (DSS)-induced intestinal injury in a Drosophila melanogaster (fruit fly) model.
The compounds decreased markers of barrier leakage, epithelial cell death, stem-cell overproliferation, and oxidative stress; AMP80-1 showed stronger effects than AMP80-2 on several readouts. RT-qPCR results in the fly suggested modulation of p38/JNK and Upd/JAK/STAT–related stress and regenerative pathways.
These results come from an animal (invertebrate) model and are presented as a research-focused abstract. They do not demonstrate effects in mammals or humans, and the study does not provide clinical evidence for use in people with IBD. The findings are preliminary and useful mainly for researchers exploring mechanisms or early-stage therapeutic leads.
Keep In Mind
Findings are from Drosophila (fruit fly) experiments described in an abstract; they are preliminary and do not establish safety or efficacy in mammals or humans.
Source Details
Review the original publication for the complete reporting, methods, and context.
Research paper
Evidence type derived from source or registry metadata.
PublicationInternational journal of biological macromolecules
AuthorsQiuye Heng, Junhao Li, Qian Zhang +4 more
InstitutionThe Affiliated Dongguan Songshan Lake Central Hospital, School of Pharmacy, Guangdong Medical University, Dongguan, 523808, China.
Study typeJournal article
Indexed viaPubMed
Source typeResearch paper
PublishedAug 28, 2026, 12:00 AM
Content availableJournal abstract
Conflict statement: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Sanggenol L Regulates Nrf2/HO-1/p65 Signalling Pathways via Dextran Sulfate Sodium-Induced Ulcerative Colitis in Mice
Researchers exploring new anti-inflammatory or antioxidant compounds for ulcerative colitis may find sanggenol L’s effects on Nrf2/HO-1 and TLR4/p65 signalling of interest. Patients should note this is early-stage,...
Caulerpa peltata extract protects against Dextran sodium sulfate-induced acute ulcerative colitis via modulating Nrf2 pathway
People with IBD might be interested because the study explores a new natural-product intervention that appears to reduce colitis severity in an animal model by activating the Nrf2 antioxidant pathway — a pathway already...
Extracellular Vesicles Derived from Elaeocarpus braceanus Alleviate DSS-Induced Ulcerative Colitis in Mice Through Multiple Pathways
This study describes a new plant-derived nanoparticle (EBDEVs) that reduced inflammation and improved colon health in a mouse model of ulcerative colitis and altered the gut microbiota — early evidence that may guide...